(CXDO) Crexendo - Overview
Stock: Cloud, Communications, Platform, Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 56.2% |
| Relative Tail Risk | -11.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | -6.19 |
| Character TTM | |
|---|---|
| Beta | 1.794 |
| Beta Downside | 2.300 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.41% |
| CAGR/Max DD | 0.98 |
Description: CXDO Crexendo January 01, 2026
Crexendo, Inc. (NASDAQ: CXDO) delivers a cloud-based communications platform and unified communications-as-a-service (UCaaS) to enterprise customers in the U.S. and abroad. The business is split between a Cloud Telecommunications Services segment, which sells and leases IP-telephony equipment and provides managed network services, and a Software Solutions segment, which offers the SNAP suite (hosted PBX, auto-attendant, call-center, video-conferencing, and mobility) plus the SaaS-based SNAPaccel platform. Revenue is generated through a mix of hardware sales, subscription licences, and professional services such as consulting, design, and resident-engineer support.
In its most recent fiscal year (FY 2023), Crexendo reported roughly $70 million of total revenue, with annual recurring revenue (ARR) of about $55 million and a year-over-year growth rate near 12 %. Gross margins hovered around 65 %, reflecting the high-margin nature of its software licences, while the company still posted a modest net loss as it invests in sales-and-marketing expansion. The UCaaS market is being propelled by sustained remote-work adoption, enterprise cloud-spending acceleration, and the rollout of 5G, which together underpin a projected CAGR of ~10 % through 2029.
Given Crexendo’s position in a fast-growing sector and its transition toward recurring-revenue models, analysts should watch churn rates, the pace of hardware-to-software conversion, and cash-flow conversion trends to gauge whether the company can achieve sustainable profitability.
For a deeper quantitative look at Crexendo’s valuation metrics, the ValueRay platform offers a concise dashboard of its key financial ratios.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 4.36m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.16 > 1.0 |
| NWC/Revenue: 38.76% < 20% (prev 21.64%; Δ 17.12% < -1%) |
| CFO/TA 0.12 > 3% & CFO 9.13m > Net Income 4.36m |
| Net Debt (-27.2m) to EBITDA (7.93m): -3.43 < 3 |
| Current Ratio: 2.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.8m) vs 12m ago 6.57% < -2% |
| Gross Margin: 67.34% > 18% (prev 0.62%; Δ 6672 % > 0.5%) |
| Asset Turnover: 96.01% > 50% (prev 94.39%; Δ 1.61% > 0%) |
| Interest Coverage Ratio: 159.9 > 6 (EBITDA TTM 7.93m / Interest Expense TTM 29.0k) |
Altman Z'' -6.83
| A: 0.34 (Total Current Assets 39.3m - Total Current Liabilities 13.6m) / Total Assets 76.0m |
| B: -1.09 (Retained Earnings -82.9m / Total Assets 76.0m) |
| C: 0.07 (EBIT TTM 4.64m / Avg Total Assets 69.1m) |
| D: -5.66 (Book Value of Equity -82.7m / Total Liabilities 14.6m) |
| Altman-Z'' Score: -6.83 = D |
Beneish M -3.05
| DSRI: 1.17 (Receivables 6.34m/4.79m, Revenue 66.3m/58.8m) |
| GMI: 0.92 (GM 67.34% / 61.67%) |
| AQI: 0.80 (AQ_t 0.46 / AQ_t-1 0.58) |
| SGI: 1.13 (Revenue 66.3m / 58.8m) |
| TATA: -0.06 (NI 4.36m - CFO 9.13m) / TA 76.0m) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of CXDO shares?
Over the past week, the price has changed by -3.71%, over one month by +5.58%, over three months by +0.29% and over the past year by +22.16%.
Is CXDO a buy, sell or hold?
- StrongBuy: 6
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CXDO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.9 | 27.4% |
| Analysts Target Price | 8.9 | 27.4% |
| ValueRay Target Price | 7.9 | 13.4% |
CXDO Fundamental Data Overview January 29, 2026
P/S = 3.2933
P/B = 3.5618
Revenue TTM = 66.3m USD
EBIT TTM = 4.64m USD
EBITDA TTM = 7.93m USD
Long Term Debt = 114.0k USD (from longTermDebt, last fiscal year)
Short Term Debt = 723.0k USD (from shortTermDebt, last quarter)
Debt = 1.38m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.2m USD (from netDebt column, last quarter)
Enterprise Value = 191.3m USD (218.5m + Debt 1.38m - CCE 28.6m)
Interest Coverage Ratio = 159.9 (Ebit TTM 4.64m / Interest Expense TTM 29.0k)
EV/FCF = 21.06x (Enterprise Value 191.3m / FCF TTM 9.08m)
FCF Yield = 4.75% (FCF TTM 9.08m / Enterprise Value 191.3m)
FCF Margin = 13.69% (FCF TTM 9.08m / Revenue TTM 66.3m)
Net Margin = 6.57% (Net Income TTM 4.36m / Revenue TTM 66.3m)
Gross Margin = 67.34% ((Revenue TTM 66.3m - Cost of Revenue TTM 21.7m) / Revenue TTM)
Gross Margin QoQ = 79.06% (prev 63.41%)
Tobins Q-Ratio = 2.52 (Enterprise Value 191.3m / Total Assets 76.0m)
Interest Expense / Debt = 0.22% (Interest Expense 3000 / Debt 1.38m)
Taxrate = 2.88% (43.0k / 1.49m)
NOPAT = 4.50m (EBIT 4.64m * (1 - 2.88%))
Current Ratio = 2.89 (Total Current Assets 39.3m / Total Current Liabilities 13.6m)
Debt / Equity = 0.02 (Debt 1.38m / totalStockholderEquity, last quarter 61.3m)
Debt / EBITDA = -3.43 (Net Debt -27.2m / EBITDA 7.93m)
Debt / FCF = -2.99 (Net Debt -27.2m / FCF TTM 9.08m)
Total Stockholder Equity = 56.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.31% (Net Income 4.36m / Total Assets 76.0m)
RoE = 7.71% (Net Income TTM 4.36m / Total Stockholder Equity 56.6m)
RoCE = 8.18% (EBIT 4.64m / Capital Employed (Equity 56.6m + L.T.Debt 114.0k))
RoIC = 7.90% (NOPAT 4.50m / Invested Capital 57.0m)
WACC = 12.45% (E(218.5m)/V(219.9m) * Re(12.53%) + D(1.38m)/V(219.9m) * Rd(0.22%) * (1-Tc(0.03)))
Discount Rate = 12.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.93%
[DCF Debug] Terminal Value 53.13% ; FCFF base≈8.14m ; Y1≈5.34m ; Y5≈2.44m
Fair Price DCF = 1.78 (EV 27.5m - Net Debt -27.2m = Equity 54.7m / Shares 30.7m; r=12.45% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 21.11 | EPS CAGR: -32.36% | SUE: -4.0 | # QB: 0
Revenue Correlation: 94.32 | Revenue CAGR: 19.41% | SUE: 1.33 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=5
EPS next Year (2026-12-31): EPS=0.35 | Chg30d=-0.001 | Revisions Net=+1 | Growth EPS=+1.9% | Growth Revenue=+11.5%